BHA
GILD icon

Beech Hill Advisors’s Gilead Sciences GILD Stock Holding History

Beech Hill Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Sell
8,390
-1,098
-12% -$154K 0.59% 64
2025
Q4 		$1.16M Sell
9,488
-390
-4% -$47.4K 0.56% 64
2025
Q3 		$1.1M Sell
9,878
-1,155
-10% -$131K 0.51% 67
2025
Q2 		$1.22M Sell
11,033
-3,155
-22% -$336K 0.55% 65
2025
Q1 		$1.59M Sell
14,188
-55
-0.4% -$5.67K 0.63% 57
2024
Q4 		$1.32M Sell
14,243
-345
-2% -$31.1K 0.49% 61
2024
Q3 		$1.22M Buy
14,588
+226
+2% +$17.2K 0.46% 62
2024
Q2 		$985K Sell
14,362
-685
-5% -$45.7K 0.41% 61
2024
Q1 		$1.1M Buy
15,047
+585
+4% +$45K 0.46% 59
2023
Q4 		$1.17M Buy
14,462
+60
+0.4% +$4.67K 0.57% 54
2023
Q3 		$1.08M Buy
14,402
+197
+1% +$15.2K 0.54% 57
2023
Q2 		$1.09M Buy
14,205
+2,000
+16% +$160K 0.53% 54
2023
Q1 		$1.01M Sell
12,205
-560
-4% -$46.4K 0.51% 56
2022
Q4 		$1.1M Hold
12,765
– – 0.61% 52
2022
Q3 		$787K Buy
12,765
+180
+1% +$11.4K 0.45% 54
2022
Q2 		$778K Buy
12,585
+825
+7% +$51.1K 0.42% 62
2022
Q1 		$699K Buy
11,760
+940
+9% +$60.1K 0.29% 67
2021
Q4 		$786K Buy
+10,820
New +$745K 0.3% 66
2020
Q1 		– Sell
-8,725
Closed -$567K – 77
2019
Q4 		$567K Sell
8,725
-175
-2% -$11.4K 0.26% 55
2019
Q3 		$564K Hold
8,900
– – 0.3% 54
2019
Q2 		$601K Hold
8,900
– – 0.32% 53
2019
Q1 		$579K Buy
8,900
+1,350
+18% +$89.7K 0.36% 50
2018
Q4 		$472K Hold
7,550
– – 0.29% 48
2018
Q3 		$583K Hold
7,550
– – 0.3% 51
2018
Q2 		$535K Buy
7,550
+575
+8% +$40.6K 0.3% 51
2018
Q1 		$526K Sell
6,975
-4,000
-36% -$318K 0.28% 51
2017
Q4 		$786K Buy
10,975
+500
+5% +$38K 0.39% 48
2017
Q3 		$849K Buy
10,475
+3,600
+52% +$275K 0.45% 44
2017
Q2 		$487K Sell
6,875
-66,550
-91% -$4.43M 0.27% 57
2017
Q1 		$4.99M Buy
73,425
+31,195
+74% +$2.19M 2.87% 6
2016
Q4 		$3.02M Buy
42,230
+3,450
+9% +$256K 1.81% 28
2016
Q3 		$3.07M Buy
+38,780
New +$3.15M 1.88% 27
2016
Q1 		– Sell
-36,815
Closed -$3.73M – 71
2015
Q4 		$3.73M Sell
36,815
-4,350
-11% -$453K 2.36% 16
2015
Q3 		$4.04M Sell
41,165
-758
-2% -$84.2K 2.57% 12
2015
Q2 		$4.91M Sell
41,923
-20,529
-33% -$2.24M 2.52% 14
2015
Q1 		$6.13M Sell
62,452
-2,915
-4% -$296K 2.88% 9
2014
Q4 		$6.16M Buy
65,367
+12,267
+23% +$1.27M 3.07% 9
2014
Q3 		$5.65M Sell
53,100
-1,355
-2% -$133K 2.67% 7
2014
Q2 		$4.51M Buy
+54,455
New +$4.24M 1.99% 22

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Beech Hill Advisors's GILD Position: Q1 2026 in Review

Beech Hill Advisors reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $154K and leaving 8,390 shares worth $1.17M. The position accounts for 0.59% of the portfolio, ranked #64.

Beech Hill Advisors first reported a position in GILD in Q2 2014 and has held it in 39 quarters since. The position peaked at $6.16M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Beech Hill Advisors held 8,390 shares of Gilead Sciences worth $1.17M as of Q1 2026.
  • Beech Hill Advisors sold 1,098 Gilead Sciences shares in Q1 2026, an estimated $154K.
  • Gilead Sciences made up 0.59% of Beech Hill Advisors's portfolio in Q1 2026, its #64 holding.
  • Beech Hill Advisors first reported a position in Gilead Sciences in Q2 2014 and has held it in 39 quarters since.
  • Beech Hill Advisors's Gilead Sciences position peaked at $6.16M in Q4 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Beech Hill Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.